Skip to main content
Caplight Logo









AIDO

AIDO

Private
StrasbourgHealthcare & Life Scienceshttps://aido.health

Last Round

Grant

Feb 2, 2026

Total Funding Raised

$160,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AIDO operates in Healthcare & Life Sciences and is based in Strasbourg. Its latest recorded funding round was a Grant round in February 2026.

AIDO is a medical device company that develops endoscopy technology designed to facilitate non-invasive complex procedures for the early diagnosis and treatment of digestive cancers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AIDO Comparables

Compare AIDO with similar companies based on industry and business-model similarity.

AIDO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Atlas Endoscopy
34%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AIDO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 2, 2026
SeedSep 8, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Charlotte Cavé

Founder and Chief Executive Officer

Founding Team

For institutional investors. Book with your work email.

AIDO Investors

Notable investors and investment history

AIDO investors
InvestorRounds
Région Grand EstGrant
BpifranceSeed
NLC Health VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors grew 369% MoM, from 489 to 2.3K.

  • Feb 2, 2026

    $160K raised from Région Grand Est

Book a demo to see all signals

For institutional investors. Book with your work email.

AIDO Filings

Explore SEC and related filing metadata, where available.

AIDO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AIDO's valuation, stock price, and market status.

Is AIDO a public or private company?

AIDO is a private company.

What is the current stock price of AIDO?

AIDO is a private company, so its shares have no public market price. Caplight tracks AIDO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AIDO worth (valuation)?

Valuation information for AIDO is not publicly available.

Can I buy AIDO stock?

AIDO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AIDO's last funding round?

AIDO's most recent funding round was Grant on February 2, 2026.

Who are the main investors in AIDO?

Key investors in AIDO include NLC Health Ventures.

Will AIDO IPO soon?

No public IPO plans have been announced for AIDO.

How can I track AIDO secondary market activity?

Caplight tracks bids, offers, and trades in AIDO's shares on secondary markets.

Firmographic Details

HeadquartersStrasbourg
Employee Range2
Year Founded2022
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?